On July 29, 2026, the U.S. Food and Drug Administration granted De Novo classification to Smith+Nephew’s TESSA Spatial Surgery System — the first device authorized in an entirely new FDA category for intra-articular orthopedic stereotaxic navigation. In plain terms:...read more